Page 2 - Oxford University

Indian-origin Meghana Pandit named CEO of Oxford University Hospitals

Professor Meghana Pandit, a leading Indian-origin medic was appointed the chief executive officer (CEO) of the Oxford University Hospitals NHS Foundation Trust, one of the UK's largest teaching hospitals. Pandit becomes the trust's first female chief and she is also the first person of Indian heritage to be appointed CEO of any National Health Service (NHS) trust in the Shelford Group, which represents some of the biggest teaching hospitals in the country. Pandit, who was serving as the interim CEO at Oxford University Hospitals (OUH) since July 2022, was permanently appointed to the post following a rigorous and competitive process, which concluded after what OUH described as an extensive national and international recruitment search. It is a privilege to be asked to lead OUH on a permanent basis and I look forward to continue working with colleagues at OUH, our partners in the health and social care system in Oxfordshire and across the BOB Integrated Care System, our partner ...

Here's how Oxford zeroes in on its word of the year as people vote for 2022

As OUP leaves the word of the year to a people's vote, here's how the process works

As China intensifies Covid-19 lockdowns, India gradually opens up

Data shows that spike in one country has not coincided with a rise the other

7 Indian universities on Global Employability University Ranking, IIT-D top

Seven Indian universities featured on the list released by the Times Higher Education

Poverty in India fell by 415 million in 15 yrs; still has maximum poor: UN

Global Multidimensional Poverty Index has revealed that COVID-19 pandemic had set progress in reducing poverty back by 3-10 years

A remarkable teacher: Remembering D-School's Elizabeth Krishna

Elizabeth Krishna worked at the Delhi School of Economics for about a decade and a half from the mid-1960s to late 1970s as a tutor, or teaching assistant

Oxford University shifts focus to health threat triggering future pandemics

Oxford said the organization will seek to learn from the response to Covid and take advantage of the university's research and global partnerships

Covid-19: Experts bat for mixing vaccines in the wake of BA.2.75 variant

Senior research fellow at Oxford say BA.2.75 has several mutations in the spike protein, two of which are unique to it when compared to its parent strain BA.2

Four women who took on the Oxford establishment

The biographical material in Metaphysical Animals is evocative and sparkling

India invited to join G7 Health Ministers' Summit virtually: UK Government

India is among the guest countries invited to join virtually at the 2021 G7 Health Ministers' Meeting to be held at Oxford University on June 3 and 4

The fine art of sustainable living

This is a deeply personal memoir of a woman born in New Jersey, whose Native American Osage mother and her family introduced her to nature and spirituality early on

UK marks Oxford/AstraZeneca Covid-19 vaccine's one-year anniversary

Our fight against COVID in the UK and around the world would not have been possible without the Oxford/AstraZeneca vaccine, said PM Boris Johnson

Billionaire Poonawalla family pledges $66 mn to Oxford for research campus

The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world's largest maker of vaccines

Oxford study backs mixing of Covid vaccines, no safety concerns raised

The study supports flexible use of these vaccines in primary immunisation schedules

Oxford scientists find gene that doubles risk of dying from Covid-19

Scientists identified a specific gene that doubles the risk of respiratory failure from Covid-19

Covid caused biggest decrease in life expectancy since World War II: Study

The study found that 27 of the 29 countries saw reductions in life expectancy in 2020, and at a scale which wiped out years of progress on mortality.

Pfizer and Astra vaccines less effective after 90 days, says study

The Oxford University study found that 90 days after a second shot of the Pfizer or Astra vaccine, their efficacy in preventing infections had slipped to 75 per cent and 61 per cent, respectively

Pfizer, AstraZeneca vaccines less effective against Delta variant: Study

The COVID vaccines by Pfizer and AstraZeneca are less effective against the Delta variant compared to the Alpha variant, according to a study led by researchers at the University of Oxford

Oxford study says mixing Covid-19 vaccines gives robust protection

This study, published on the Lancet pre-print server, means all possible vaccination schedules involving the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could potentially be used against Covid-19

AstraZeneca, Oxford Univ tests Covid booster shots against Beta-variant

British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant